Soleno Therapeutics, Inc.
SLNO
$73.64
$0.380.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.50% | -3.51% | 77.86% | -11.82% | 223.59% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 72.31% | 3.19% | -13.60% | -4.83% | 37.23% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.82% | -3.48% | 76.89% | -11.75% | 219.35% |
|
|
|||||
| Total Current Assets | 13.82% | -3.48% | 76.89% | -11.75% | 219.35% |
| Net Property, Plant & Equipment | -6.40% | 1,010.80% | -21.37% | -12.89% | -14.31% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -6.67% | -6.25% | -5.88% | -5.55% | -5.26% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | -49.70% | 0.00% | 0.00% |
| Total Assets | 11.55% | -2.44% | 80.13% | -6.56% | 184.34% |
|
|
|||||
| Total Accounts Payable | 42.27% | 68.00% | -53.68% | 154.75% | -2.08% |
| Total Accrued Expenses | 27.70% | 28.86% | 10.80% | -44.53% | 37.87% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.41% | 51.35% | -4.52% | 13.55% | 6.64% |
| Total Finance Division Other Current Liabilities | -11.74% | 175.40% | -25.48% | -2.83% | -92.52% |
| Total Other Current Liabilities | -11.74% | 175.40% | -25.48% | -2.83% | -92.52% |
| Total Current Liabilities | 25.30% | 63.52% | -32.04% | 17.03% | -60.32% |
|
|
|||||
| Total Current Liabilities | 25.30% | 63.52% | -32.04% | 17.03% | -60.32% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.22% | -- | -- | -71.54% | -39.25% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.41% | 1.69% | 19.03% | 3.47% | 3.85% |
| Total Liabilities | 168.25% | 36.93% | -8.16% | 9.78% | -42.51% |
|
|
|||||
| Common Stock & APIC | 5.59% | 9.91% | 36.09% | 1.70% | 50.49% |
| Retained Earnings | -14.13% | -23.97% | -7.34% | -7.74% | -4.26% |
| Treasury Stock & Other | -59.66% | 684.97% | -44.34% | -- | -- |
| Total Common Equity | -7.40% | -5.72% | 95.81% | -8.97% | 578.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.40% | -5.72% | 95.81% | -8.97% | 578.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.40% | -5.72% | 95.81% | -8.97% | 578.32% |
|
|
|||||